Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Nitric Oxide For The Treatment Of Hypoxic Respiratory Failure With Pulmonary Hypertension In Preterm Infants

NCT00922532 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT00922532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00922532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Nitric Oxide For The Treatment Of Hypoxic Respiratory Failure With Pulmonary Hypertension In Preterm Infants
Lead sponsor
Mallinckrodt
Phase
Phase 3
Overall status
Withdrawn
Start date
November 30, 2009
Completion date
October 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic respiratory failure with pulmonary hypertension